Cargando…

Do Candida albicans Isolates with Borderline Resistant Micafungin MICs Always Harbor FKS1 Hot Spot Mutations?

Antifungal susceptibility testing is important in guiding patient therapy due to an increasing number of resistant Candida isolates. In the clinical strain collection of the Austrian resistance report (AURES), a high number of micafungin-resistant C. albicans isolates (18.2% 49/269) was detected in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spettel, Kathrin, Galazka, Sonia, Kriz, Richard, Camp, Iris, Willinger, Birgit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911425/ https://www.ncbi.nlm.nih.gov/pubmed/33525326 http://dx.doi.org/10.3390/jof7020093

Ejemplares similares

Novel Non-Hot Spot Modification in Fks1 of Candida auris Confers Echinocandin Resistance
por: Kordalewska, Milena, et al.
Publicado: (2023)

The Emergence of Echinocandin-Resistant Candida glabrata Exhibiting High MICs and Related FKS Mutations in Turkey
por: Sig, Ali Korhan, et al.
Publicado: (2021)

Glutathione Metabolism in Candida albicans Resistant Strains to Fluconazole and Micafungin
por: Maras, Bruno, et al.
Publicado: (2014)

Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis
por: Gil-Alonso, Sandra, et al.
Publicado: (2015)

Candida auris in Austria—What Is New and What Is Different
por: Spettel, Kathrin, et al.
Publicado: (2023)

Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the fks Mutants
por: Cheung, Yuk-Yam, et al.
Publicado: (2017)

Species Distribution of Candidemia and Their Susceptibility in a Single Japanese University Hospital: Prior Micafungin Use Affects the Appearance of Candida parapsilosis and Elevation of Micafungin MICs in Non-parapsilosis Candida Species
por: Sakamoto, Yasutaka, et al.
Publicado: (2021)

In vitro interactions of nystatin and micafungin combined with chlorhexidine against Candida albicans isolates
por: Salehi, Maede, et al.
Publicado: (2022)

Differential Regulation of Echinocandin Targets Fks1 and Fks2 in Candida glabrata by the Post-Transcriptional Regulator Ssd1
por: Healey, Kelley R., et al.
Publicado: (2020)

Novel FKS1 and FKS2 modifications in a high-level echinocandin resistant clinical isolate of Candida glabrata
por: Hou, Xin, et al.
Publicado: (2019)

Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin
por: Shirazi, Fazal, et al.
Publicado: (2015)

An Optimized Lock Solution Containing Micafungin, Ethanol and Doxycycline Inhibits Candida albicans and Mixed C. albicans – Staphyloccoccus aureus Biofilms
por: Lown, Livia, et al.
Publicado: (2016)

Colourful FKS subtraction
por: Frixione, Stefano
Publicado: (2011)

The Fungicidal Action of Micafungin is Independent on Both Oxidative Stress Generation and HOG Pathway Signaling in Candida albicans
por: Alonso-Monge, Rebeca, et al.
Publicado: (2020)

Two echinocandin-resistant Candida glabrata FKS mutants from South Africa
por: Naicker, Serisha D., et al.
Publicado: (2016)

Rapid emergence of FKS mutations in Candida glabrata isolates in a peritoneal candidiasis
por: Sasso, Milène, et al.
Publicado: (2017)

The FKS gravitational lens survey
por: Kochanek, C S, et al.
Publicado: (1995)

Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing
por: Spettel, Kathrin, et al.
Publicado: (2019)

Minimal Inhibitory Concentration (MIC)-Phenomena in Candida albicans and Their Impact on the Diagnosis of Antifungal Resistance
por: Binder, Ulrike, et al.
Publicado: (2019)

382. Virulence in Candida glabrata Is Not Attenuated by FKS Mutations but Associated With the Frequency of Cells With Distinct Morphology
por: Hu, Chenlin, et al.
Publicado: (2018)

Pan-Echinocandin Resistant C. parapsilosis Harboring an F652S Fks1 Alteration in a Patient with Prolonged Echinocandin Therapy
por: Siopi, Maria, et al.
Publicado: (2022)

Successful treatment of Candida tropicalis osteomyelitis with Micafungin in a leukemia patient
por: Ma, Liya, et al.
Publicado: (2016)

Foster Kennedy Syndrome (FKS): A Case Report
por: Musa, Mutali, et al.
Publicado: (2022)

Synergistic Interaction of Caspofungin Combined with Posaconazole against FKS Wild-Type and Mutant Candida auris Planktonic Cells and Biofilms
por: Balla, Noémi, et al.
Publicado: (2022)

Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC)
por: López-Sánchez, Cristina, et al.
Publicado: (2020)

A case of Candida glabrata severe urinary sepsis successfully treated with micafungin
por: Pieralli, Filippo, et al.
Publicado: (2014)

Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report
por: Yamada, Shoko Merrit, et al.
Publicado: (2016)

Streptococcus mutans Membrane Vesicles Harboring Glucosyltransferases Augment Candida albicans Biofilm Development
por: Wu, Ruixue, et al.
Publicado: (2020)

Automation of next-to-leading order computations in QCD: the FKS subtraction
por: Frederix, Rikkert, et al.
Publicado: (2009)

A case of breakthrough Candida parapsilosis fungemia during micafungin therapy for a Candida glabrata bloodstream infection
por: Norimatsu, Yuta, et al.
Publicado: (2017)

Persistent candida arthritis successfully treated with micafungin instillation and surgery. A case report
por: van Egmond, Jeroen C., et al.
Publicado: (2019)

Evaluation of the synergistic antifungal activity of micafungin and voriconazole plus sertraline against Candida auris
por: Alanís-Ríos, Sergio A., et al.
Publicado: (2022)

Rapid Evolution of Multidrug Resistance in a Candida lusitaniae Infection during Micafungin Monotherapy
por: Scott, Nancy E., et al.
Publicado: (2023)

Successful therapy of Candida pulcherrima fungemia in a premature newborn with liposomal amphotericin B and micafungin
por: Mpakosi, Alexandra, et al.
Publicado: (2016)

Micafungin Is an Efficient Treatment of Multi Drug-Resistant Candida glabrata Urosepsis: A Case Report
por: Javorova Rihova, Zuzana, et al.
Publicado: (2021)

A case of bloodstream co-infection of Saccharomyces cerevisiae and Candida glabrata while using micafungin
por: Furuya, Kento, et al.
Publicado: (2023)

Case Report: Echinocandin-Resistance Candida glabrata FKS Mutants From Patient Following Radical Cystoprostatectomy Due to Muscle-Invasive Bladder Cancer
por: Szymankiewicz, Maria, et al.
Publicado: (2021)

Pooled analysis of safety for micafungin
por: Cornely, OA, et al.
Publicado: (2008)

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
por: Wasmann, Roeland E., et al.
Publicado: (2017)

Candida albicans enriched in orthodontic derived white spot lesions and shaped focal supragingival bacteriome
por: Yang, Hao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sms5ot3hujvep3algvr8lq4ca9